Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intratympanic Injection for Autoimmune Inner Ear Disease (AIED)

This study has been terminated.
(House Research no longer conducting research.)
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
House Research Institute
ClinicalTrials.gov Identifier:
NCT01526174
First received: February 1, 2012
Last updated: October 10, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)